Physician profile
Shelly Smith
NPI 1730263500
$1,246.91
in general payments reported to CMS, 2019-2025
21 companies · $16.64 in 2025
The $16.64 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $466 · 2022: $261 · 2023: $489 · 2024: $14.38 · 2025: $16.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $471.66 | 2021-2025 | |
| Astellas Pharma US INC | $133.45 | 2022-2023 | Veozah, Myrbetriq |
| Medical Device Business Services, INC. | $108.13 | 2023 | Stratafix |
| Exeltis, USA INC. | $91.27 | 2022-2023 | Nuvessa |
| Mayne Pharma Commercial LLC | $76.65 | 2023 | |
| Currax Pharmaceuticals LLC | $38.83 | 2021-2022 | |
| Braintree Laboratories, INC. | $36.66 | 2021 | |
| Myovant Sciences INC. | $34.28 | 2021-2022 | |
| Pfizer INC. | $30.35 | 2023 | |
| Vivus LLC | $30.07 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $26.00 | 2021 | |
| Ibsa Pharma INC. | $21.64 | 2023 | Tirosint, Licart |
| Agile Therapeutics, INC. | $21.59 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $21.53 | 2023 | Vivjoa |
| Millicent US INC | $18.65 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $16.34 | 2023 | Stratafix |
| Sumitomo Pharma America, INC. | $15.08 | 2023 | Myfembree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.71 | 2022 | |
| Invivyd INC | $14.38 | 2024 | Pemgarda |
| Biohaven Pharmaceuticals, INC. | $13.11 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.